Fundz

Efferon raises €2.5M in seed funding led by DACH private investors to expand its blood purification platform across Europe.

PRIVATEMay 21, 2026

Amount Raised

€2.5 Million

Round Type

Seed

BernBiotechnologyHealth Care

Investors

Private Investors From The Dach Region

Description

Efferon has raised €2.5 million in a seed funding round to support the European commercial expansion of its hemoadsorption device, Efferon LPS. This funding will help address the urgent need for treatments in sepsis and septic shock. The company's portfolio includes innovative devices aimed at improving patient outcomes. With this investment, Efferon aims to solidify its position in the market and broaden its applications.

Quick answer

Efferon raised €2.5 Million in a Seed round, dated May 21, 2026. Investors: Private Investors From The Dach Region. Efferon is based in Bern, Switzerland.

How much did Efferon raise?
Efferon raised €2.5 Million in a Seed round on May 21, 2026.
Who invested in Efferon?
Private Investors From The Dach Region is named as investors in this round.
What does Efferon do?
Efferon develops multimodal hemoadsorption therapeutic devices designed to remove endotoxins and inflammatory mediators directly from the bloodstream.
Where is Efferon based and how big is it?
Efferon is based in Bern, Switzerland.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Efferon that raised within 45 days of this round, from Fundz verified event records.

  • Axten Hospitals raised $262K (Seed) on July 5, 2026.
  • LigaChem Biosciences raised $357M (Post-IPO Equity) on July 4, 2026.
  • ARIBIO raised $28M (Corporate Round) on July 3, 2026.
  • Gestala Technology raised $66M (Angel) on July 3, 2026.
  • NewcelX raised $2.9M on July 3, 2026.
  • Rosota raised $965K (Seed) on July 2, 2026.

Who to call at Efferon, and when

A new round usually means Efferon is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Efferon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Efferon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Efferon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Efferon

Location

Bern, Switzerland

About

Efferon develops multimodal hemoadsorption therapeutic devices designed to remove endotoxins and inflammatory mediators directly from the bloodstream. Its product portfolio includes Efferon LPS, a hemoadsorption cartridge for treatment of sepsis and septic shock, and Efferon NEO, developed for pediatric use. The company aims to reduce ICU treatment costs by supporting faster stabilization of septic shock. Efferon's technology has been used in over 25,000 treatments globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Efferon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Efferon's next move

See what Strategic adds

Efferon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.